http://bmctoday.net/glaucomatoday/ The latest news stories from Glaucoma Today. en-us Sat, 13 Mar 2010 13:28:19 GMT Sat, 13 Mar 2010 13:28:19 GMT BMCToday http://bmctoday.net/glaucomatoday/2010/02/article.asp?f=emglaucoma-todayem-applies-for-business-publication-membership-in-bpa-worldwide Glaucoma Today has applied for Business of Performing Audits (BPA) Worldwide business publication membership. For 12 months, BPA Worldwide will conduct an initial audit of Glaucoma Today’s circulation, which will be tracked based on distribution, demographics, and geographic coverage. “The strong growth of Glaucoma Today has made it a pe... Tue, 2 Feb 2010 04:00:00 GMT http://bmctoday.net/glaucomatoday/2010/02/article.asp?f=emglaucoma-todayem-applies-for-business-publication-membership-in-bpa-worldwide http://bmctoday.net/glaucomatoday/2010/02/article.asp?f=dennis-singleton-receives-glaucoma-research-foundations-visionary-award The Glaucoma Research Foundation (GRF) named Dennis Singleton the 2009 recipient of its Visionary Award. As a long-time member of the GRF’s board, Mr. Singleton was honored for his dedication to the cause of glaucoma research and education. According to a news release, Mr. Singleton has served on the GRF’s board of directors since 1998 an... Tue, 2 Feb 2010 04:00:00 GMT http://bmctoday.net/glaucomatoday/2010/02/article.asp?f=dennis-singleton-receives-glaucoma-research-foundations-visionary-award http://bmctoday.net/glaucomatoday/2010/02/article.asp?f=short-wavelength-automated-perimetry-may-not-predict-glaucoma-conversion The results of a prospective, longitudinal study failed to support the idea that short-wavelength automated perimetry (SWAP) predicts a conversion to glaucoma 3 to 4 years earlier than standard automated perimetry (SAP). Four hundred sixteen patients with ocular hypertension were tested twice a year during a 7- to 10-year period until the ons... Tue, 2 Feb 2010 04:00:00 GMT http://bmctoday.net/glaucomatoday/2010/02/article.asp?f=short-wavelength-automated-perimetry-may-not-predict-glaucoma-conversion http://bmctoday.net/glaucomatoday/2010/02/article.asp?f=alcon-to-enter-surgical-glaucoma-market Alcon, Inc. (Huenenberg, Switzerland), announced that it has entered into a definitive agreement to acquire Optonol, Ltd. (Neve Ilan, Israel), a medical device company that develops, manufactures, and markets miniature surgical implants used to lower IOP in patients with glaucoma. With this acquisition, Alcon will reportedly acquire Optonol�... Tue, 2 Feb 2010 04:00:00 GMT http://bmctoday.net/glaucomatoday/2010/02/article.asp?f=alcon-to-enter-surgical-glaucoma-market http://bmctoday.net/glaucomatoday/2010/02/article.asp?f=insite-vision-to-advance-new-ocular-anti-inflammatory-drug-candidate InSite Vision, Inc. (Alameda, CA), recently announced plans to advance new development candidate ISV-303, a topical anti-inflammatory product intended to reduce the pain and swelling associated with ocular surgery. InSite Vision formulated a lower concentration of bromfenac, a topical nonsteroidal anti-inflammatory product approved in the Uni... Tue, 2 Feb 2010 04:00:00 GMT http://bmctoday.net/glaucomatoday/2010/02/article.asp?f=insite-vision-to-advance-new-ocular-anti-inflammatory-drug-candidate http://bmctoday.net/glaucomatoday/2010/02/article.asp?f=panasonic-assists-pixeloptics-in-the-development-of-electronic-eye-glasses PixelOptics, Inc. (Roanoke, VA), announced that it is collaborating with Panasonic Shikoku Electronics Co., Ltd. (Matsuyama, Japan), on the development of electronic eye glasses. PixelOptics will develop, market, and sell the world’s first static (fixed focus) and electronic dynamic (changeable focus) lenses. “Pixel’s electronic eyeglas... Tue, 2 Feb 2010 04:00:00 GMT http://bmctoday.net/glaucomatoday/2010/02/article.asp?f=panasonic-assists-pixeloptics-in-the-development-of-electronic-eye-glasses http://bmctoday.net/glaucomatoday/2010/02/article.asp?f=indiana-university-researcher-receives-235-million-from-nih-for-glaucoma-research William H. Swanson, PhD, professor at Indiana University School of Optometry, received a $2.35 million grant from the National Institutes of Health to further his glaucoma research. According to a news release, Dr. Swanson’s research group will conduct a study on improved methods for screening and testing for the presence, progression, and ... Tue, 2 Feb 2010 04:00:00 GMT http://bmctoday.net/glaucomatoday/2010/02/article.asp?f=indiana-university-researcher-receives-235-million-from-nih-for-glaucoma-research http://bmctoday.net/glaucomatoday/2010/02/article.asp?f=novartis-raises-its-stake-in-the-fast-growing-eye-care-business In a move to diversify its business and gain ground in the rapidly growing global eye care business, Novartis AG (Basel, Switzerland) announced in January a deal to purchase a majority stake in Alcon, Inc. (Huenenberg, Switzerland). Novartis said it would pay $28.1 billion for a majority stake in Alcon, with plans to acquire the rest of the s... Tue, 2 Feb 2010 04:00:00 GMT http://bmctoday.net/glaucomatoday/2010/02/article.asp?f=novartis-raises-its-stake-in-the-fast-growing-eye-care-business http://bmctoday.net/glaucomatoday/2009/12/article.asp?f=1109NEWS_10.php A WORD ON BLEBSThe following reader/author exchange is in reference to an editorial by Richard A. Lewis, MD, and an article titled “Closing the Fornix-Based Flap” by Craig Marcus, MD, and Garry P. Condon, MD. Both appeared in our October 2009 edition. In his editorial, Dr. Lewis commented that glaucoma blebs are the bane of the glau... Wed, 2 Dec 2009 04:00:00 GMT http://bmctoday.net/glaucomatoday/2009/12/article.asp?f=1109NEWS_10.php http://bmctoday.net/glaucomatoday/2009/12/article.asp?f=1109NEWS_09.php Tissue Bank International (Baltimore, MD) has announced the availability of the VisionGraft Sterile Cornea, a sterile corneal allograft for use in tectonic transplant procedures. It is ready to use at room temperature and has a shelf life of 1 year. According to a press release, the allograft dramatically reduces the risk of disease transmiss... Wed, 2 Dec 2009 04:00:00 GMT http://bmctoday.net/glaucomatoday/2009/12/article.asp?f=1109NEWS_09.php http://bmctoday.net/glaucomatoday/2009/12/article.asp?f=1109NEWS_08.php ASICO LLC (Westmont, IL) debuted its Neuhann USC Glaucoma Marker: AE-1529 and Kitahara Glaucoma Punch: AE-8304 at the 2009 AAO Annual Meeting in San Francisco. The Kitahara Glaucoma Punch’s 1.0-mm X 1.0-mm square 360° tip reportedly can be moved to any position. According to the company, the Neuhann USC Glaucoma Marker can mark a pa... Wed, 2 Dec 2009 04:00:00 GMT http://bmctoday.net/glaucomatoday/2009/12/article.asp?f=1109NEWS_08.php http://bmctoday.net/glaucomatoday/2009/12/article.asp?f=1109NEWS_07.php In a phase 2a study, a Rho-kinase (ROCK) inhibitor (AR- 12286; Aerie Pharmaceuticals, Inc., Bridgewater, NJ) produced a statistically significant decrease in IOP with q.d. and b.i.d. dosing. The study enrolled 88 patients with primary open-angle glaucoma or ocular hypertension. According to Aerie, AR-12286 lowered mean IOP by a maximum of 28% ... Wed, 2 Dec 2009 04:00:00 GMT http://bmctoday.net/glaucomatoday/2009/12/article.asp?f=1109NEWS_07.php